about
Tropomyosin-related kinase B/brain derived-neurotrophic factor signaling pathway as a potential therapeutic target for colorectal cancerFine-tuning roles of endogenous brain-derived neurotrophic factor, TrkB and sortilin in colorectal cancer cell survivalA new role under sortilin's belt in cancerImmunophenotypic lymphocyte profiles in human african trypanosomiasis.Serum neurotrophin profile in systemic sclerosisDot enzyme-linked immunosorbent assay for more reliable staging of patients with Human African trypanosomiasis.Endogenous neurotrophins and Trk signaling in diffuse large B cell lymphoma cell lines are involved in sensitivity to rituximab-induced apoptosis.Hallmarks in colorectal cancer: angiogenesis and cancer stem-like cellsNeurotrophins are expressed in giant cell arteritis lesions and may contribute to vascular remodeling.Serum and lymphocytic neurotrophins profiles in systemic lupus erythematosus: a case-control study.IL22/IL-22R pathway induces cell survival in human glioblastoma cells.Anti-apoptotic role and clinical relevance of neurotrophins in diffuse large B-cell lymphomasRetinoid acid receptors in human colorectal cancer: An unexpected link with patient outcome.Frequency of central lesions in polyneuropathy associated with IgM monoclonal gammopathy: an MRI, neurophysiological and immunochemical studyp75 neurotrophin receptor and pro-BDNF promote cell survival and migration in clear cell renal cell carcinoma.TrkB-containing exosomes promote the transfer of glioblastoma aggressiveness to YKL-40-inactivated glioblastoma cells.Psychoactive drugs influence brain-derived neurotrophic factor and neurotrophin 4/5 levels in the serum of colorectal cancer patientsKLRC3, a Natural Killer receptor gene, is a key factor involved in glioblastoma tumourigenesis and aggressivenessThe implications of sortilin/vps10p domain receptors in neurological and human diseases.The Ins and Outs of Nanoparticle Technology in Neurodegenerative Diseases and Cancer.New ex-ovo colorectal-cancer models from different SdFFF-sorted tumor-initiating cells.Autophagy and TrkC/NT-3 signaling joined forces boost the hypoxic glioblastoma cell survival.Sortilin mediates the release and transfer of exosomes in concert with two tyrosine kinase receptors.Sedimentation field flow fractionation monitoring of in vitro enrichment in cancer stem cells by specific serum-free culture medium.In vitro induction of microglial and endothelial cell apoptosis by cerebrospinal fluids from patients with human African trypanosomiasis.Cross-reactivity of anti-galactocerebroside autoantibodies with a Trypanosoma brucei proteolipidic epitope.Improved sedimentation field-flow fractionation separation channel for concentrated cellular elution.Autophagy takes place in mutated p53 neuroblastoma cells in response to hypoxia mimetic CoCl(2).Photodynamic treatment induces cell death by apoptosis or autophagy depending on the melanin content in two B16 melanoma cell lines.Differential expression of neurotensin and specific receptors, NTSR1 and NTSR2, in normal and malignant human B lymphocytes.Autophagic subpopulation sorting by sedimentation field-flow fractionation.E-cadherin: A potential biomarker of colorectal cancer prognosis.Cancer stem cell sorting from colorectal cancer cell lines by sedimentation field flow fractionation.TLR4 signal transduction pathways neutralize the effect of Fas signals on glioblastoma cell proliferation and migration.Glycosylation-related gene expression is linked to differentiation status in glioblastomas undifferentiated cells.Development of a downscale sedimentation field flow fractionation device for biological event monitoring.Role of endogenous brain-derived neurotrophic factor and sortilin in B cell survival.Increase of Fas-induced apoptosis by inhibition of extracellular phosphorylation of Fas receptor in Jurkat cell line.Sedimentation field flow fractionation purification of immature neural cells from a human tumor neuroblastoma cell line.In vitro induction of neuronal apoptosis by anti-Fas antibody-containing sera from amyotrophic lateral sclerosis patients.
P50
Q26774713-29A3CF3E-BF49-4194-8B66-43AED32F1ADDQ28249554-99C7C701-FA0E-45D1-9662-DCD4BCCFD98DQ28274718-F219F8DE-BF13-46B0-ACF0-2348AD8A9B9EQ33479514-4AFCF48B-0CCC-4C77-92CD-963687609971Q33749854-42FD0EC6-D134-4D4E-A814-3CDCBCE7F089Q34042327-98C162DF-A202-460D-93D4-0170F5440777Q34072659-AD2EEEB8-78C2-4FA7-B302-912344654123Q34661510-B5D73612-C949-4A45-8153-EB444D268FAFQ34761856-82FBECFB-3861-4734-8A79-14C73E9DF359Q35041314-229C72C1-D8E5-4892-AA29-50167317F3C2Q35203455-D88A7A51-000B-4F37-8060-B3A88CFBB964Q36081364-7BABDB88-6C53-401A-BB3E-205BD75C896DQ36230780-861C8CA4-9793-49BE-B1F5-C13BD81C2CCFQ36958393-060DADB1-66DD-4668-B8D0-831B4EA12175Q37376314-C7AA02C0-0F0E-4D4C-A574-80B2B310E78CQ37580396-C7E32C28-6E1D-4E13-A172-653B1B6BB253Q37593863-8AA8BC1F-B2C1-49EC-A949-97C791F87CA1Q37604367-91E46192-9C99-4A59-A990-8EE6F6E2364EQ38262766-D7352414-FECC-4DE8-AFBB-6BADF58EF0A2Q38564661-CAA91F7C-4E5D-4374-9524-5760F6F67811Q38831002-AECFC2F0-2440-471E-97B9-74869F4C7F11Q38840711-C9E896E4-D9F1-476B-81FF-55F2258AA080Q38974186-976AABBE-DD29-4856-A399-BD169A1E8A80Q38985088-B386A8B7-08CC-4366-AFD6-B08F814ABEB1Q39024438-7F621E76-7668-4708-8562-5536AF5F43D7Q39024442-7181F25D-A2D5-4F92-9E02-3E5BC22FB237Q39136720-5FE229AC-2F90-424A-B50D-9A55850B59C7Q39199771-779F1A22-3E9D-4DC6-B463-E71D0CCE0414Q39225706-EACB855C-0B1E-41A9-906C-F667FCAD2AB7Q39251679-508ACC1C-756C-4C44-B59E-8EBFD8AB722AQ39273042-C7EC7B1A-287F-4103-83FB-A3513A6ED0EEQ39355560-9B94B411-C7D5-4166-842C-3D6C3EC8546AQ39413781-405BD77A-4E4F-4F4D-A33E-C2346835B53CQ39488455-DEF4C7F8-41C9-4F32-9E04-BB79020DF145Q39709840-781D1C52-E20D-4105-9EE4-7EFB2FD580DDQ39803230-0D3CA4EB-0723-48BD-A6FB-B63EEFE513A9Q39949116-182B4457-436C-463A-A086-7CB03F6A1C5CQ40279966-A17A1097-F9F3-41A0-AF81-54CBCF54C19EQ40582404-CC16A24E-16CC-429A-8A0D-E5E35FD4E3EBQ40853966-91AC37AE-2661-48B7-AC77-58D5A5929A5B
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Marie-Odile Jauberteau
@ast
Marie-Odile Jauberteau
@en
Marie-Odile Jauberteau
@es
Marie-Odile Jauberteau
@nl
Marie-Odile Jauberteau
@sl
type
label
Marie-Odile Jauberteau
@ast
Marie-Odile Jauberteau
@en
Marie-Odile Jauberteau
@es
Marie-Odile Jauberteau
@nl
Marie-Odile Jauberteau
@sl
prefLabel
Marie-Odile Jauberteau
@ast
Marie-Odile Jauberteau
@en
Marie-Odile Jauberteau
@es
Marie-Odile Jauberteau
@nl
Marie-Odile Jauberteau
@sl
P214
P106
P1153
7003451720
P214
P31
P496
0000-0002-8811-8948
P7859
viaf-195989767